Contents
2.Once the HTA secretariat receives the information from the European Medicines Agency pursuant to Article 3, it shall make that information available for further analysis in the preparation of the recommendation referred to in Article 7(4) of Regulation (EU) 2021/2282 to the following:
(a)the Coordination Group;
(b)the EHT Subgroup or the JCA Subgroup, based on the decision of the Coordination Group; or
(c)the Coordination Group and the EHT Subgroup or the JCA Subgroup, based on the decision of the Coordination Group.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.